Promising clinical data surrounding this compound, specifically the 120 milligram formulation branded as ZPHC, suggest a considerable impact on weight loss and associated health factors. Experts believe that this combined compound, influencing both GLP-1 and GIP systems, may offer a major breakthrough in the treatment of obesity and associated dis